Forian Inc.

Forian Inc.

FORAยทNASDAQ

$2.17

+0.0000%
HealthcareMedical - Healthcare Information Services

Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$67.79M
EPS-0.0924
P/E Ratio-22.95
Earnings Date08/12/2026
3Y+84.0%
5Y+5453.0%
10Y-
3Y-89.0%
5Y-42.0%
10Y+123.0%
3Y-134.0%
5Y-168.0%
10Y-380.0%
Forian Inc.

Forian Inc. Profit Bridge

FORA ยท NASDAQ
Revenue30.26M
Cost of Goods Sold (14.36M)
Gross Profit15.89M
Operating Expenses (18.36M)
Operating Income-2.47M
Interest Expense (142.35K)
Other Income/Expense-177.38K
Pretax Income-2.65M
Income Tax (227.97K)
Net Income-2.87M
Net Income
-2.87M

Profitability Analysis

Gross Margin

52.5%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

-8.2%

Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.

Net Profit Margin

-9.5%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

Forian Inc. Income Statement

FORA โ€ข NASDAQ

Forian Inc. Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
REVENUE
30.3M
20.2M
20.5M
16.4M
16.9M
544.9K
0.0
GROSS PROFIT
(14.4M)
(7.3M)
(5.5M)
(5M)
(4.7M)
(38.3K)
(854.0)
15.9M
12.8M
15M
11.4M
12.2M
506.6K
-854.0
OPERATING INCOME
(18.4M)
(19.8M)
(20.6M)
(30.3M)
(39.8M)
(5.5M)
(1.3M)
(15.4M)
(16.9M)
(18.5M)
(20.8M)
(27.6M)
(2.1M)
(463.8K)
(2.9M)
(1.4M)
(1.4M)
(4M)
(9M)
(2.5M)
(827.5K)
-2.5M
-7M
-5.6M
-19M
-27.6M
-5M
-1.3M
PRE-TAX INCOME
(142.4K)
(708.9K)
(834.8K)
(846.1K)
(322.4K)
(0.0)
(0.0)
1.1M
1.7M
1.5M
-579.9K
-315.6K
3.6K
0.0
(0.0)
(1.5M)
(674.3K)
(5.5M)
(3.2M)
(872K)
(0.0)
-177.4K
3.3M
7.4M
-215.2K
1.1M
3.6K
3.3K
-2.6M
-3.7M
1.8M
-19.2M
-26.5M
-5M
-1.3M
NET INCOME
(228K)
(66.6K)
(85.7K)
(24K)
(22.5K)
(0.0)
-4.0
-2.9M
-3.8M
11.1M
-26M
-26.6M
-5M
-1.3M

SEC Filings

FORA - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 15, 2026
May 15, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 15, 2026
March 31, 2026
2026
10-K/A

10-K/A 2025 FY (Amended)

FY

April 30, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

April 03, 2026
April 02, 2026
2026
10-K

10-K 2025 FY

FY

March 27, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

March 27, 2026
March 27, 2026
2026
8-K

8-K 2026

N/A

January 12, 2026
January 08, 2026
2026
DEF 14A

DEF 14A 2026

N/A

December 15, 2025
January 08, 2026
2026
10-Q

10-Q 2025 Q3

Q3

November 14, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 14, 2025
November 14, 2025
2025
Showing 1 to 10 of 78 filings